PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31229637 ↗2019Mixed findings

Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.

MouseTBIControlled cortical impactC57BL/6MaleIntraperitoneal50 mg/kg1 h before traumatic brain injury or sham surgery

Model: Moderate controlled impact traumatic brain injury in the paediatric mouse

Glycyrrhizin lowered brain HMGB1 and oedema at 3 days and prevented short-term spatial memory and motor learning deficits and apparent hippocampal microglial reactivity, but did not reduce evoked seizure severity, the proportion of animals with chronic spontaneous seizures, or cortical tissue loss.

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.